新加坡在2027年推出AI工具,以预测糖尿病和胆固醇风险,从而能够从2026年年中开始尽早进行筛查和扩大遗传癌症风险覆盖范围。 Singapore launches AI tool in 2027 to predict diabetes and cholesterol risk, enabling earlier screenings and expanded genetic cancer risk coverage starting mid-2026.

新加坡将在2027年初推出AI工具, 用于预测糖尿病和高胆固醇风险, Singapore will launch an AI tool in early 2027 to predict diabetes and high cholesterol risk, identifying patients with over a 75% chance of diagnosis within three years. 该工具在1 100个诊所使用,将建议每年对高风险个人进行有补贴的心脏筛查,每三年增加一次。 The tool, used in 1,100 clinics, will recommend annual subsidized heart screenings for high-risk individuals, up from every three years. 遗传癌症风险预防性手术将从2026年年中开始部分覆盖,遗传检测将从2026年12月起补贴,并提供咨询。 Preventive surgeries for hereditary cancer risks will be partially covered starting mid-2026, and genetic testing will be subsidized from December 2026, with counseling provided. AI支持但不能取代临床决定。 AI supports, but does not replace, clinical decisions.